Impact of Frailty on Postoperative Complications in Oncosurgery
NCT ID: NCT05721391
Last Updated: 2023-07-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2022-03-01
2023-07-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Frailty and Postoperative Outcomes After Gastric Cancer Surgery
NCT03568110
Complex Peri-operative Intervention in Older Patients With Cancer
NCT04709055
The Patient in Laparoscopic Colon Surgery:Impact of Comorbidities,Frailty,Malnutrition and Sarcopenia on Short-term Mortality
NCT04729738
Fatigue and QoL Among Gastric Cancer Patients Undergoing Abdominal Surgery
NCT03766945
Frailty Score and Postoperative Morbidity in Colorectal Cancer Surgery
NCT06866678
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All patients will receive standard general anaesthesia along with Epidural for Abdomino-pelvic surgeries.Intraoperative monitoring 5 lead ECG, NIBP/IBP , SPO2, ETCO2, CVP(Optional),BIS will be done.After induction of anaesthesia Ultrasonography will be performed with curvilinear probe --- at the midpoint of femur anteriorly to measure Rectus Femoris muscle thickness of Right thigh , three consecutive readings will be measured and average of value noted for all patients.
At the end of surgery patient's neuromuscular block will be reversed and trachea extubated , if any patient requires ventilator support note will be made accordingly. Postoperative patients vitals and Input/Output charting will be done .Postoperative analgesia either epidural analgesia or intravenous opioids according to Institutional protocol will be given .Length of ICU Stay and any major cardiac , respiratory , Renal complications , re-exploration will be noted.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non Frail Group
The patients in no frail group did not have any component of Frailty criteria
No interventions assigned to this group
Pre Frail Group
The patients in prefrail Group had 1-2 component of Frailty criteria.
No interventions assigned to this group
Frail Group
The patients in Frail Group had 3-5 component of Frailty criteria.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Age \<65 years.
* Emergency surgery
* Pre-existing dementia
* Language barrier
65 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rajiv Gandhi Cancer Institute & Research Center, India
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Anita Kulkarni
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anita Kulkarni, MD
Role: PRINCIPAL_INVESTIGATOR
Rajiv Gandhi Cancer Institute and Research Centre , Delhi , India
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rajiv Gandhi Cancer Institute and Research Centre
New Delhi, National Capital Territory of Delhi, India
Rajiv Gandhi Cancer Institute
Delhi, , India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RGCI Frailty
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.